N/A
N=117
Effectiveness and Implementation of the HiBalance Program in Clinical Practice
Parkinson Disease
Bottom Line
View on ClinicalTrials.gov: NCT02727478 ↗Enrolled (actual)
117
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: Change in Mini-BESTest Score From Baseline at 1 Week Post Intervention. — 2.0; -0.2 score on a scale — p=< 0.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- HiBalance training program (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Karolinska Institutet
- Primary completion
- Feb 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Mini-BESTest Score From Baseline at 1 Week Post Intervention. |
2.0; -0.2 | < 0.001 sig |
| SECONDARY Change in 10-meter Walking Test Score From Baseline at 1 Week Post Intervention. |
0.2; -0.04 | =0.001 sig |
| SECONDARY Change in Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention. |
-0.4; 0 | 0.254 |
| SECONDARY Change in EQ-5D Score From Baseline at 1week Post Intervention. |
5.5; 0 | =0.065 |
| SECONDARY Change in Activities-specific Balance Confidence (ABC) Scale |
68; 70 | =0.301 |
| SECONDARY Change in Physical Activity Level From Baseline 1 Week Post Intervention. |
-288; -390 | =0.792 |
| SECONDARY Change in Dual Task Interference During the Timed Up and Go (TUG) Test From Baseline at 1 Week Post Intervention. |
-1.22; 1.05 | 0.039 sig |
Summary
This effectiveness-implementation study is a part of the larger study BETA-PD (Balance, Elderly, Training and Activity in Parkinson's Disease), which has the long-term goal to reduce the risk of falling in people with Parkinson's disease (PD) by improving balance, gait and physical activity level. The main hypothesis is that highly challenging balance training will lead to greater gait and balance ability, increased levels of physical activity and an improved health related quality of life. The main aims of the study are to evaluate the effectiveness of the HiBalance program in real-life clinical settings, while exploring facilitators and barriers for program implementation on a wider scale.
Eligibility Criteria
Inclusion Criteria
- Diagnosed idiopathic Parkinson's Disease
- Measured balance impairment (according to the mini-BESTest)
- Hoehn and Yahr stages 2-3
- Independent ambulator indoors without a walking aid
Exclusion Criteria
- Cognitive impairment which hinders participation in group training
- The presence of comorbidities which hinder safe participation in group training
Data sourced from ClinicalTrials.gov (NCT02727478). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.